The Effectiveness of Basal Plus Compared with Premixed Insulin in Insulin-Naive Type 2 Diabetes Patients

被引：0
|
作者：
Raghavan, Arun
Nanditha, Arun
Satheesh, Krishnamoorthy
Snehalatha, Chamukuttan
Seeli, Abraham Catherin
Simon, Mary
Susairaj, Priscilla
Ramachandran, Ambady
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-2332-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2332-PUB
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Comparison of biphasic premixed insulin versus once daily basal insulin in insulin-naive veteran patients with type 2 diabetes
    Grisham-Takac, Catlin
    Yeary, Julianne
    Edwards, Krystal
    Chastain, Lisa
    Kelly, Kevin C.
    [J]. PHARMACOTHERAPY, 2015, 35 (11): : E259 - E259
  • [2] TYPE 2 DIABETES SIMULATOR FOR TESTING BASAL INSULIN THERAPY IN INSULIN-NAIVE PATIENTS
    Visentin, R.
    Schiavon, M.
    Riz, M.
    Goebel, B.
    Klabunde, T.
    Dalla Man, C.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A69 - A70
  • [3] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Insulin-naive Chinese Patients With Type 2 Diabetes
    Cheng, Huafeng
    Wan, Xu
    Ma, Jing
    Wu, Bin
    [J]. CLINICAL THERAPEUTICS, 2019, 41 (03) : 445 - 455
  • [4] Adherence and persistence to a regimen of basal insulin in a pre-filled pen compared to vial/syringe in insulin-naive patients with type 2 diabetes
    Buysman, Erin
    Conner, Christopher
    Aagren, Mark
    Bouchard, Jonathan
    Liu, Fang
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (09) : 1709 - 1717
  • [5] A retrospective database analysis of insulin use patterns in insulin-naive patients with type 2 diabetes initiating basal insulin or mixtures
    Bonafede, Machaon M. K.
    Kalsekar, Anupama
    Pawaskar, Manjiri
    Ruiz, Kimberly M.
    Torres, Amelito M.
    Kelly, Karen R.
    Curkendall, Suellen M.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2010, 4 : 147 - 156
  • [6] The Impact of Diabetes Duration on Safety and Effectiveness of Insulin Analogs in Insulin-Naive People with Type 2 Diabetes
    Home, Philip
    Khattab, Mohammed
    Swaraj, Soji
    Feriz, Karen
    Prusty, Vinay
    Ghannam, Nadia
    [J]. DIABETES, 2014, 63 : A226 - A226
  • [7] Basal insulin peglispro versus insulin glargine in insulin-naive type 2 diabetes: IMAGINE 2 randomized trial
    Davies, M. J.
    Russell-Jones, D.
    Selam, J. -L.
    Bailey, T. S.
    Kerenyi, Z.
    Luo, J.
    Bue-Valleskey, J.
    Ivanyi, T.
    Hartman, M. L.
    Jacobson, J. G.
    Jacober, S. J.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (11): : 1055 - 1064
  • [8] Cost-effectiveness of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients With Type 2 Diabetes Mellitus
    Brown, Stephen T.
    Grima, Daniel Grima
    Sauriol, Luc
    [J]. CLINICAL THERAPEUTICS, 2014, 36 (11) : 1576 - 1587
  • [9] Metabolic Effects of Basal or Premixed Insulin Treatment in 5077 Insulin-Naive Type 2 Diabetes Patients: Registry-Based Observational Study in Clinical Practice
    Eliasson, Bjorn
    Ekstrom, Nils
    Wirta, Sara Bruce
    Oden, Anders
    Fard, MirNabi Pirouzi
    Svensson, Ann-Marie
    [J]. DIABETES THERAPY, 2014, 5 (01) : 243 - 254
  • [10] Treatment to target in Type 2 diabetes: consistent risk reduction of hypoglycaemia with basal insulin glargine as compared with NPH insulin in insulin-naive patients on oral agents.
    Rosenstock, J
    Riddle, M
    [J]. DIABETOLOGIA, 2002, 45 : A259 - A259
12345